---
category: news
title: "Seizing “magic moment” for machine learning, startup Seismic unveils $101M"
excerpt: "Machine learning is core to the drug research of Seismic Therapeutic, a new biotech startup developing novel drugs for immunology indications. CEO Jo Viney said the company’s initial focus is addressing dysregulation of adaptive immunity."
publishedDateTime: 2022-02-09T12:32:00Z
originalUrl: "https://medcitynews.com/2022/02/seizing-magic-moment-for-machine-learning-startup-seismic-unveils-101m/"
webUrl: "https://medcitynews.com/2022/02/seizing-magic-moment-for-machine-learning-startup-seismic-unveils-101m/"
type: article
quality: 37
heat: 37
published: false

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://medcitynews.com/uploads/2022/02/JoViney_cropped.jpg"
    width: 1503
    height: 1002
    isCached: true

secured: "Ps4+O3pzYG8GJRgJWlHRo3Cfv2z8zNDs2Dp/chUCo+UMyxtLxPqpidFdYxurTBpgdRydkY0SIl05T9vAE9SprBbtj8MnNrudbI0FGUumegBAqcNsgo+q617WFv/wmq1FxGYWFzl9dHBMUqii8HrdMehMng8GOt5hzoBwpR/ev0r2fX9Z+IjGXg/8Bi6Zz0s4MzYuN9rAICEem8WUeEOT5dy/Kv3XwjHlQvFJewVQd+LKxVEmzZ75DVQ+mUrGUPOXxy7RMeeIF90zkvSob4jHXAwQYLoDSMtOACWO8eGvrK8aoduKSDTUjT3y+85CN3j/L+tPmz50hjC3yM8TOoDYWwMIaYnc8kLGPxw0Dmfth+U=;DFPm3NuF9+LNw7UlGV0Cyg=="
---

